Cholangiocarcinoma, also known as bile duct cancer, is the second most common primary
hepatic carcinoma with a median survival of less than 2 years. The molecular mechanisms …

Despite progress in the diagnostics and treatment of hepatocellular carcinoma (HCC), its
prognosis remains poor. In this study, we globally assessed long noncoding RNAs (lncRNA) for …

Multilayer microcapsules with ultrathin wall thickness (in the nanometer range) and predesigned
shape and size have been recently fabricated and extensively studied [1, 2]. Applying …

Pancreaticoduodenectomy (Whipple procedure) has been the standard treatment for
periampullary and pancreatic carcinoma. A leak or fistula from the pancreatic anastomosis is the …

Background Pancreatic cancer, one of the top two most fatal cancers, is characterized by a
desmoplastic reaction that creates a dense microenvironment, promoting hypoxia and …

Although a substantial increase in the survival of patients with other cancers has been
observed in recent decades, pancreatic ductal adenocarcinoma (PDAC) remains one of the …

Recent studies have revealed that long non-coding RNAs (lncRNAs) play important roles in
cancer biology and that lncRNA gas5 (growth arrest-specific 5) regulates breast cancer cell …

Objective Innate immunity plays important roles in pancreatic ductal adenocarcinoma (PDAC),
as non-T-cell-enriched tumour. Neutrophils are major players in innate immune system. …

Background Tumor resistance to chemoradiation therapy is partly attributed to the presence
of apoptosis-resistant cancer stem cells (CSCs). Chemoradiation therapy can enrich CSCs …

Long noncoding RNAs have been identified as key regulators in the progression of various
cancers. LINC00261 has been reported as a tumor suppressor in multiple cancers. However, …